Loading
ZP
Zhongzhi Pharmaceutical Holdings Ltd. Stock: price and insider trades · Hong Kong
HK·Mcap HK$548.4M
No insider purchase over the last 90 days. The latest, by Jiang Li Xia, was filed 24 Jan 2025.
Zhongzhi Pharmaceutical Holdings Ltd.: what insiders have been doing
Zhongzhi Pharmaceutical Holdings Ltd. is a listed company. Its directors and officers file their transactions with HKEX. The past year has been quiet: not a single insider filing for Zhongzhi Pharmaceutical Holdings Ltd. The previous disclosure was published on 24 January 2025.
Our records for Zhongzhi Pharmaceutical Holdings Ltd. go back to 2017, with 57 purchases and 2 sales on the open market in total.
For comparison within the same market, see the insider buying recorded at Sun Hung Kai Properties Ltd. and Xinyi Glass Holdings Ltd. Source: insider filings from HKEX. Past trades are no guide to future returns.
Insider Decl.
66
Thresholds
n/a
Buy Volume
€9M
57 ops. · all time
Sell Volume
n/a
2 ops. · all time
Who traded when
BuySaleJiang Li Xia5 buys
Lai Zhi Tian1 buy
Since the insiders bought
- -24.0%Entry HK$1.00 · Close at T+365 HK$0.76
- -24.0%Entry HK$1.00 · Close at T+365 HK$0.76
- +60.9%Entry HK$0.87 · Close at T+365 HK$1.40
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 3,203 of 26,281 companies
72.3
score / 100
Value88
Quality56
FCF yld7.2%
Earn yld17%
EV/EBITDA3.2x
ROE1.6%
Gross mgn58%
Net mgn4.3%
Debt/EBITDA1.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2024FY ended December 2024 · cache
HK$0.65
Analyst consensus
Income statement
RevenueHK$2.2B
Gross profitHK$1.3B58% margin
EBITDAHK$265.3M12% margin
Net incomeHK$95.2M1.1% margin
Valuation
PER (trailing)32.5x
P/Book0.4x
Beta0.37
Balance sheet & cash
Market capHK$548.4M
Total debtHK$301.2M
Free Cash FlowHK$39.6M
Debt / Equity8%
Profitability & ownership
ROE1.6%
ROA0.5%
% insiders75.8%
% institutions0.0%
Last declaration on 24 January 2025
Declarations66 total
50,000 shares@ HK$1.030.1% of flowShareXHKGHKEX:DA20250124E00029
Canonical exit: 23 Apr 2025 (T+90)
50,000 shares@ HK$1.030.1% of flowShareXHKGHKEX:DA20250124E00026
Canonical exit: 23 Apr 2025 (T+90)
30,000 shares@ HK$0.980.1% of flowShareXHKGHKEX:DA20250122E00502
Canonical exit: 22 Apr 2025 (T+90)
80,000 shares@ HK$0.960.2% of flowShareXHKGHKEX:DA20250121E00121
Canonical exit: 21 Apr 2025 (T+90)
200,000 shares@ HK$0.930.5% of flowShareXHKGHKEX:DA20250121E00119
Canonical exit: 20 Apr 2025 (T+90)
839,000 shares@ HK$1.002.3% of flowShareXHKGHKEX:DA20250108E00049
Canonical exit: 7 Apr 2025 (T+90)
5,000,000 shares@ HK$1.2015.8% of flowShareXHKGHKEX:DA20240419E00340
Canonical exit: 18 Jul 2024 (T+90)
5,000,000 shares@ HK$1.2010.9% of flowShareXHKGHKEX:DA20240419E00339
Canonical exit: 18 Jul 2024 (T+90)
3,162,000 shares@ HK$1.237.1% of flowShareXHKGHKEX:DA20240416E00433
Canonical exit: 15 Jul 2024 (T+90)
3,162,000 shares@ HK$1.2310.2% of flowShareXHKGHKEX:DA20240416E00434
Canonical exit: 15 Jul 2024 (T+90)
2,259,000 shares@ HK$1.17017.0% of flowShareXHKGHKEX:DA20240415E00513
Canonical exit: 14 Jul 2024 (T+90)
2,259,000 shares@ HK$1.17014.8% of flowShareXHKGHKEX:DA20240415E00512
Canonical exit: 14 Jul 2024 (T+90)
3,198,000 shares@ HK$1.2010.0% of flowShareXHKGHKEX:DA20240412E00376
Canonical exit: 11 Jul 2024 (T+90)
3,198,000 shares@ HK$1.206.9% of flowShareXHKGHKEX:DA20240412E00374
Canonical exit: 11 Jul 2024 (T+90)
2,680,000 shares@ HK$1.218.4% of flowShareXHKGHKEX:DA20240411E00481
Canonical exit: 10 Jul 2024 (T+90)
2,680,000 shares@ HK$1.215.9% of flowShareXHKGHKEX:DA20240411E00479
Canonical exit: 10 Jul 2024 (T+90)
3,050,000 shares@ HK$1.15189.1% of flowShareXHKGHKEX:DA20240403E00540
Canonical exit: 2 Jul 2024 (T+90)
3,050,000 shares@ HK$1.15186.3% of flowShareXHKGHKEX:DA20240403E00538
Canonical exit: 2 Jul 2024 (T+90)
1,000,000 shares@ HK$1.423.7% of flowShareXHKGHKEX:DA20231115E00330
Canonical exit: 13 Feb 2024 (T+90)
1,000,000 shares@ HK$1.422.5% of flowShareXHKGHKEX:DA20231115E00313
Canonical exit: 13 Feb 2024 (T+90)
344,000 shares@ HK$1.35621.2% of flowShareXHKGHKEX:DA20230919E00370
Canonical exit: 18 Dec 2023 (T+90)
344,000 shares@ HK$1.35620.8% of flowShareXHKGHKEX:DA20230919E00364
Canonical exit: 18 Dec 2023 (T+90)
104,000 shares@ HK$1.29880.4% of flowShareXHKGHKEX:DA20230906E00015
Canonical exit: 4 Dec 2023 (T+90)
104,000 shares@ HK$1.29880.2% of flowShareXHKGHKEX:DA20230906E00014
Canonical exit: 4 Dec 2023 (T+90)
1,623,000 shares@ HK$1.32355.5% of flowShareXHKGHKEX:DA20230905E00380
Canonical exit: 29 Nov 2023 (T+90)
25 of 66 declarations
About Zhongzhi Pharmaceutical Holdings Ltd.
Recent ranked signals on the same market
Purchases our model currently ranks for the recommendations list.
All recommendations